137 related articles for article (PubMed ID: 37599165)
1. Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis.
Guo W; Lin Y; Hu S; Shen Y
Clin Ther; 2023 Oct; 45(10):973-976. PubMed ID: 37599165
[TBL] [Abstract][Full Text] [Related]
2. Comparison of efficacy between levonorgestrel intrauterine system and dienogest in adenomyosis: a randomized clinical trial.
Choudhury S; Jena SK; Mitra S; Padhy BM; Mohakud S
Ther Adv Reprod Health; 2024; 18():26334941241227401. PubMed ID: 38283750
[TBL] [Abstract][Full Text] [Related]
3. A controlled clinical trial comparing potent progestins, LNG-IUS and dienogest, for the treatment of women with adenomyosis.
Ota I; Taniguchi F; Ota Y; Nagata H; Wada I; Nakaso T; Ikebuchi A; Sato E; Azuma Y; Harada T
Reprod Med Biol; 2021 Oct; 20(4):427-434. PubMed ID: 34646070
[TBL] [Abstract][Full Text] [Related]
4. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
Li L; Leng J; Jia S; Lang J
Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
[TBL] [Abstract][Full Text] [Related]
5. Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis.
Yang S; Liu Y; Wen J; Sun Y; Ren F
Evid Based Complement Alternat Med; 2022; 2022():1995472. PubMed ID: 35873621
[TBL] [Abstract][Full Text] [Related]
6. The role of levonorgestrel intra-uterine system in the management of adenomyosis: A systematic review and meta-analysis of prospective studies.
Abbas AM; Samy A; Atwa K; Ghoneim HM; Lotfy M; Saber Mohammed H; Abdellah AM; El Bahie AM; Aboelroose AA; El Gedawy AM; Mostafa M; Elsenity MA; Samy M; Safwat S; Abdelrahman RM; Salah El Din AS; Badran E; Abdelkader AM; Abdallah A
Acta Obstet Gynecol Scand; 2020 May; 99(5):571-581. PubMed ID: 31889294
[TBL] [Abstract][Full Text] [Related]
7. Role of levonorgestrel-releasing intrauterine system in dysmenorrhea due to adenomyosis and the influence on ovarian function.
Ji F; Yang XH; Ai Xing Zi AL; Ha Ni Ke Zi TX; He Y; Ding Y
Clin Exp Obstet Gynecol; 2014; 41(6):677-80. PubMed ID: 25566593
[TBL] [Abstract][Full Text] [Related]
8. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Sheng J; Zhang WY; Zhang JP; Lu D
Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
[TBL] [Abstract][Full Text] [Related]
9. [A prospective cohort study on effects of levonorgestrel-releasing intrauterine system for adenomyosis with severe dysmenorrhea].
Li L; Leng JH; Dai Y; Zhang JJ; Jia SZ; Li XY; Shi JH; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):345-51. PubMed ID: 27256441
[TBL] [Abstract][Full Text] [Related]
10. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
[TBL] [Abstract][Full Text] [Related]
11. Levonorgestrel-Releasing Intrauterine System Improves Menorrhagia-Related Quality of Life in Patients with Symptomatic Adenomyosis.
Ishizawa C; Hirota Y; Iida R; Kaku T; Hirata T; Fukui Y; Omura E; Akaeda S; Hiraoka T; Matsuo M; Osuga Y
Reprod Sci; 2023 Mar; 30(3):966-973. PubMed ID: 36071343
[TBL] [Abstract][Full Text] [Related]
12. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of high-intensity focused ultrasound ablation combined with mifepristone and levonorgestrel-releasing intrauterine system to treat symptomatic adenomyosis.
Zhu H; Ma Q; Dong G; Yang L; Li Y; Song S; Mu Y
Int J Hyperthermia; 2023; 40(1):2161641. PubMed ID: 36586419
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of dienogest with symptomatic adenomyosis: retrospective analysis of efficacy and safety in clinical practice.
Miao J; Lu J; Tang J; Lu P
Gynecol Endocrinol; 2022 Aug; 38(8):656-660. PubMed ID: 35850637
[No Abstract] [Full Text] [Related]
15. Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis.
Zhao TT; Pang LL; Yang LL; Li RN; Fan LX; Wen Y
Arch Gynecol Obstet; 2023 Aug; 308(2):351-362. PubMed ID: 35947146
[TBL] [Abstract][Full Text] [Related]
16. Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: A prospective observational study (J-MIRAI).
Harada T; Ota I; Kitawaki J; Momoeda M; Maeda N; Akira S; Umeyama M; Sunaya T; Hirano K
Contraception; 2022 Dec; 116():22-28. PubMed ID: 36057322
[TBL] [Abstract][Full Text] [Related]
17. Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: a prospective clinical trial.
Zheng J; Xia E; Li TC; Sun X
J Reprod Med; 2013; 58(7-8):285-90. PubMed ID: 23947077
[TBL] [Abstract][Full Text] [Related]
18. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
Fong YF; Singh K
Contraception; 1999 Sep; 60(3):173-5. PubMed ID: 10640162
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.
Lee KH; Jung YW; Song SY; Kang BH; Yang JB; Ko YB; Lee M; Han HY; Yoo HJ
J Obstet Gynaecol Res; 2018 Sep; 44(9):1779-1786. PubMed ID: 29974633
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis.
Zhang P; Song K; Li L; Yukuwa K; Kong B
Med Princ Pract; 2013; 22(5):480-3. PubMed ID: 23796720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]